DRUG STUDY

Name: Ruby R. Santillan BSN

Drugs Dose Method of Indications Effect on Effect on

Administration Labor Mother &
Progress Effect on
Fetus
Morphine 0.2 to 2.3 Subcutaneous, Relief of May reduce Morphine
Sulfate mg/kg/dose Intramuscular moderate to the strength, may affect
PO every 12 or Intravenous severe acute and duration and baby’s
hours route. chronic pain frequency of development
where use of an uterine in the first
opioid analgesic contractions trimester
is appropriate resulting in taking
prolonged morphine at
labor the end of
pregnancy
has a risk that
the baby will
get
withdrawal
symptoms
when they’re
born
Bupivacaine 2 mg/kg By injection Local or regional It produces
(without anesthesia good sensory
epinephrine) analgesia surgical blockade with
2.5 mg/kg obstetric or minimal or no
(with diagnostic motor
epinephrine) procedures blockade
Or 150 mg
Lidocaine 5mL Subcutaneous, Local or regional Does not
(100mg/5ml ) Intramuscular, anesthetics. prolong the
As needed Intravenous Mnagement of active – first
Injection, acute ventricular and second
Transdermal arrhythmias stages of
during cardiac labor
manipulation
control of status
epilepticus
refractory to
other treatments
Thiopental IV 25 to 75 Intravenous As the sole Induces
Soduim mg; observe route only anesthetic agent tachycardia,
for 60 se. for brief ( 15 min) and incidence
 procedures of ventricular
fibrillation is
increased
Naloxone 0.4- 2 mg IV, Intravenous Reversal narcotic Significantly
Hydrochloride I/O, Nasal. Infusion induced increased the
May repeat 2 depression coma incidence of
times at 2-3 or neurological pruitos
minutes unresponsiveness
intervals. of unknown
Pediatric: 0.1 origin
mg/kg to
maximum of
2mg